DK0461039T3 - New benzimidazole-derived compounds, processes for their preparation, the intermediates obtained, their use so - Google Patents

New benzimidazole-derived compounds, processes for their preparation, the intermediates obtained, their use so

Info

Publication number
DK0461039T3
DK0461039T3 DK91401480T DK91401480T DK0461039T3 DK 0461039 T3 DK0461039 T3 DK 0461039T3 DK 91401480 T DK91401480 T DK 91401480T DK 91401480 T DK91401480 T DK 91401480T DK 0461039 T3 DK0461039 T3 DK 0461039T3
Authority
DK
Denmark
Prior art keywords
alkenyl
alkyl
preparation
image
processes
Prior art date
Application number
DK91401480T
Other languages
Danish (da)
Inventor
Michel Fortin
Daniel Frechet
Gilles Hamon
Simone Jouquey
Jean-Paul Vevert
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR909007135A external-priority patent/FR2663028B1/en
Priority claimed from FR909015811A external-priority patent/FR2670489B1/en
Priority claimed from FR9103778A external-priority patent/FR2674523A1/en
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DK0461039T3 publication Critical patent/DK0461039T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C07C233/15—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/40—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to the products: <IMAGE> in which: R represents an alkyl or alkenyl, either R1B, R2B, R3B and R5B represent hydrogen, or one of R2B and R5B represents hydrogen or -CH2-O-R10, R10 represents hydrogen, alkyl or alkenyl or <IMAGE> and one of R1B and R3B represents halogen and the other -OR6, -CO2R7 or -R11, in which: R6 and R7 represent hydrogen, alkyl or alkenyl, R11 is: a) optionally substituted alkyl, b) alkenyl, c) acyl or formyl, d): <IMAGE> or one of R1B, R2B, R3B and R5B represents hydrogen and the others are -CH2-O-R10, -OR6, -CO2R7, -R11 or <IMAGE>, R4B represents carboxyl, free, esterified or salified, or tetrazolyl, or -(CH2)m-SO2-X-R12, m representing 0 to 4 and either (-X-R12) represents NH2 or X represents a bond or -NH-, -NH-CO-NH- or -NH-CO- and R12 represents alkyl, alkenyl or aryl, products (IB) being in all the possible isomeric forms, as well as the salts, to a process for their preparation and to their use as medicaments.
DK91401480T 1990-06-08 1991-06-06 New benzimidazole-derived compounds, processes for their preparation, the intermediates obtained, their use so DK0461039T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR909007135A FR2663028B1 (en) 1990-06-08 1990-06-08 NOVEL BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION PROCESS, THE NEW INTERMEDIATES OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR909015811A FR2670489B1 (en) 1990-12-18 1990-12-18 NOVEL BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION PROCESS, THE NEW INTERMEDIATES OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR9103778A FR2674523A1 (en) 1991-03-28 1991-03-28 New benzimidazole derivatives, process for their preparation, the new intermediates obtained, their application as medicaments and the pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DK0461039T3 true DK0461039T3 (en) 1999-06-14

Family

ID=27252235

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91401480T DK0461039T3 (en) 1990-06-08 1991-06-06 New benzimidazole-derived compounds, processes for their preparation, the intermediates obtained, their use so

Country Status (11)

Country Link
EP (1) EP0461039B1 (en)
JP (1) JP3084302B2 (en)
KR (1) KR100204633B1 (en)
AT (1) ATE171177T1 (en)
AU (2) AU7820091A (en)
CA (1) CA2044124A1 (en)
DE (1) DE69130192T2 (en)
DK (1) DK0461039T3 (en)
ES (1) ES2121773T3 (en)
HU (1) HUT58061A (en)
IE (1) IE911950A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
EP0461040A1 (en) * 1990-06-08 1991-12-11 Roussel Uclaf Imidazol derivatives, their process for production, intermediates, their application as medicaments and the pharmaceutical compositions containing them
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
TW274551B (en) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
AU644540B2 (en) * 1991-09-10 1993-12-09 Tanabe Seiyaku Co., Ltd. Imidazopyridine derivatives and process for preparation thereof
TW300219B (en) * 1991-09-14 1997-03-11 Hoechst Ag
DE4315349A1 (en) * 1992-10-06 1994-11-10 Thomae Gmbh Dr K Benzimidazoles, medicaments containing these compounds and process for their preparation
NO304429B1 (en) * 1992-12-17 1998-12-14 Sankyo Co Biphenyl derivatives, pharmaceutical preparations and their use in the manufacture of a medicament for the treatment of hypertension and heart disease
DE4304455A1 (en) * 1993-02-15 1994-08-18 Bayer Ag Heterocyclic substituted phenyl-cyclohexane-carboxylic acid derivatives
CA2115985A1 (en) * 1993-02-25 1994-08-26 Kohei Nishikawa Vascular hypertrophy suppressor
JP3810020B2 (en) 1993-04-22 2006-08-16 武田薬品工業株式会社 Preventive or therapeutic agent for kidney disease
CA2125251C (en) * 1993-06-07 2005-04-26 Yoshiyuki Inada A pharmaceutical composition for angiotensin ii-mediated diseases
US5753672A (en) * 1994-04-19 1998-05-19 Tanabe Seiyaku Co., Ltd. Imidazopyridine derivatives and process for preparing the same
SE9903028D0 (en) 1999-08-27 1999-08-27 Astra Ab New use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151176A (en) * 1984-12-24 1986-07-09 Sumitomo Chem Co Ltd Benzimidazole derivative, production thereof, insecticide and acaricide comprising same as active ingredient
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
DE3928177A1 (en) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K BENZIMIDAZOLE, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
CA2016710A1 (en) * 1989-05-15 1990-11-15 Prasun K. Chakravarty Substituted benzimidazoles as angiotensin ii antagonists
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR100204633B1 (en) 1999-06-15
DE69130192D1 (en) 1998-10-22
HU911914D0 (en) 1991-12-30
DE69130192T2 (en) 1999-03-25
AU657478B2 (en) 1995-03-16
CA2044124A1 (en) 1991-12-09
AU7820091A (en) 1991-12-12
JP3084302B2 (en) 2000-09-04
EP0461039A1 (en) 1991-12-11
ES2121773T3 (en) 1998-12-16
JPH04235973A (en) 1992-08-25
HUT58061A (en) 1992-01-28
AU7824691A (en) 1991-12-12
ATE171177T1 (en) 1998-10-15
EP0461039B1 (en) 1998-09-16
IE911950A1 (en) 1991-12-18
KR920000730A (en) 1992-01-29

Similar Documents

Publication Publication Date Title
DK0461039T3 (en) New benzimidazole-derived compounds, processes for their preparation, the intermediates obtained, their use so
DK1005841T3 (en) Method of forming dental reconstructions and apparatus therefor
IL62687A0 (en) Preparation of acyl cyanides
DK20980A (en) METHOD OF PREPARING CARBOXYLIC ACID AMIDES AND PEPTIDES
ZA891408B (en) Substituted 1,2,4-triazinediones,processes for their preparation and their use
AU8866882A (en) 2-(n-hydroxycarbamoyl)phenylpropanoyl amino acids
DK375784A (en) PROCEDURE FOR THE PREPARATION OF INSULIN DERIVATIVES
BG90783A (en) METHOD FOR OBTAINING AMIDES AND GUANIDINES WITH HYPOGLYCEMICAL ACTION
BR8105587A (en) HERBICIDAL COMPOSITIONS D BASED ON CYCLE-HEXANE 1,3 DIONA
ATE371748T1 (en) METHOD FOR EPIGENETIC REGULATION OF PROTEIN BIOSYNTHESIS BY WAVE RESONANCE
DE59401372D1 (en) Process for the preparation of halomethylbenzoyl cyanides and new halomethyl benzoyl cyanides
DK0399748T3 (en) Process for the preparation of 2-oxindole-1-carboxamides
ATE214921T1 (en) NEW POTASSIUM CHANNEL AGONIST DERIVED FROM TRICHODERMA VIRENS
GB2012261A (en) Long-chain fatty acid amides and hydrazides and cyclopropano analogues thereof, their production and their use as anti-atherosclerotic agents
CZ281393B6 (en) Process for preparing 6-(substituted amino)-propionyloxyforskolin derivatives and intermediates of such process
ES494257A0 (en) PROCEDURE FOR THE PREPARATION OF A PEPTIDAMIDE
IL86943A0 (en) Process for the preparation of bicyclic amino carboxylic acids and novel compounds obtained by such process
GB1153464A (en) Amino-Fluoro-Aliphatic Dicarboxylic Acids and a process for their preparation
ES8601226A1 (en) Novel phenoxyalkylphosphinates and -phosphonates
FR2347384A1 (en) RADICAL POLYMERIZATION PROCESS USING NEW DERIVATIVES OF A- (AMINO SUBSTITUTE) ACETIC ACIDS
DE59602077D1 (en) Process for the preparation of (4,5) -trans-oxazolidine derivatives
HUT75196A (en) Method of preparing 5-chloro-4-hydroxypyrimidines, 2-chlorenamines as intermediates in the method
FR2358404A1 (en) Adamantane cpds. prepn. from pinene cpds. - intermediates for antivirals, plastics and lubricants
JPS57159750A (en) Polypeptide derivative
ES2062062T3 (en) PROCEDURE FOR THE PREPARATION OF 2-AMINO-7-HYDROXITETRALINE ETHERS.